Immuron Limited (NASDAQ: IMRN) Revenue Grew 179% While Working to Improve Immune-Related Diseases Immuron Limited (NASDAQ: IMRN), an Australian biopharmaceutical firm, specializes in oral immunotherapeutics designed to manage immune-related diseases. Despite a sharp...
Galmed Pharma Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases Galmed Pharmaceuticals (NASDAQ:GLMD) Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company for...
A Closer Look at VCI Global’s Revenue Growth and Business Model VCI Global (NASDAQ: VCIG) is a multi-disciplinary business and consulting firm, specializing in sectors such as listing solutions, strategic consultancy, fintech, AI, robotics, and cybersecurity. Since...
Organon (NYSE: OGN) to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA Cream, 1% Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, and Dermavant Sciences Ltd. announced today...
AES Corp (NYSE: AES) Announces Strategic Partnership with CDPQ to Support AES Ohio's Robust Growth Plans The AES Corporation (NYSE: AES) today announced that it reached an agreement to sell a 30% indirect equity interest in AES Ohio to CDPQ, a global investment group,...
